23 January 2025 16:17
Topic starter
0
Some people experience pain reduction after psychedelic trips. How can tripping contribute to reducing pain?
23 January 2025 20:08
Some people experience pain reduction after psychedelic trips. How can tripping contribute to reducing pain?
We do indeed see in some people with chronic pain that the pain can disappear completely during the psychedelic session. This occurs especially during psilocybin sessions for fibromyalgia and with MDMA sessions for psychosomatic complaints that lead to pain. Why is that?
The effects of psilocybin and MDMA on pain can be attributed to various mechanisms. First, there is the possibility that these substances have a direct influence on neurochemical processes in the brain. Psilocybin, for example, has been shown to possess anti-inflammatory properties, which can contribute to reducing inflammation often associated with chronic pain, such as in fibromyalgia.
Additionally, psychedelics such as psilocybin and MDMA can alter the way the brain perceives and processes pain. During a session, participants can enter a state of heightened connectedness and acceptance, enabling them to experience pain differently. This can lead to a reduction in the perception of pain, as the focus shifts from the pain itself to the emotional and psychological experiences occurring during the session.
Furthermore, psychedelic experiences can lead to deeper insights and the release of emotional blockages, which can also contribute to a reduction in pain. The combination of these factors may explain why some people experience significant pain relief during psychedelic sessions.
It is important to note that although the experiences are promising, further research is needed to fully understand the exact mechanisms and effectiveness of psychedelic therapies for chronic pain.
See also: psilocybin for inflammation
1 Answer
1
28 March 2025 11:49
We do indeed see in some people with chronic pain that the pain can disappear completely during the psychedelic session. This occurs especially during psilocybin sessions for fibromyalgia and with MDMA sessions for psychosomatic complaints that lead to pain. Why is that?
The effects of psilocybin and MDMA on pain can be attributed to various mechanisms. First, there is the possibility that these substances have a direct influence on neurochemical processes in the brain. Psilocybin, for example, has been shown to possess anti-inflammatory properties, which can contribute to reducing inflammation often associated with chronic pain, such as in fibromyalgia.
Additionally, psychedelics such as psilocybin and MDMA can alter the way the brain perceives and processes pain. During a session, participants can enter a state of heightened connectedness and acceptance, enabling them to experience pain differently. This can lead to a reduction in the perception of pain, as the focus shifts from the pain itself to the emotional and psychological experiences occurring during the session.
Furthermore, psychedelic experiences can lead to deeper insights and the release of emotional blockages, which can also contribute to a reduction in pain. The combination of these factors may explain why some people experience significant pain relief during psychedelic sessions.
It is important to note that although the experiences are promising, further research is needed to fully understand the exact mechanisms and effectiveness of psychedelic therapies for chronic pain.
See also: psilocybin for inflammation